Nipro Diagnostics Receives CE mark for TRUEresult twist 2 blood glucose monitoring system

Tuesday, 17th December 2013

Brussels, BELGIUM – December 17th, 2013 – Nipro Europe (Head Office: Brussels, Belgium) announced today the CE certification of the new blood glucose monitoring system, TRUEresult twist 2. The TRUEresult twist 2 meter offers new advanced monitoring features and will utilize the current TRUEresult test strip platform with no-coding technology. Nipro Europe will launch the new TRUEresult twist 2 meter in the first half of 2014.

Big features have been added to the small size of the TRUEresult twist2 meter

Features of the TRUEresult twist 2 blood glucose meter include a memory for up to 500 results with date- and time indication, 7-, 14-, 30- day averaging for more advanced and insightful tracking. New download capabilities with Micro USB cable allow people with diabetes and healthcare professionals to track results and see trends. TRUEresult twist 2 demonstrated accurate performance in the hands of both healthcare professionals and first-time users and exceeds the minimum accuracy criteria defined in the new, more rigorous, EN ISO 15197:2013 standard.

“Big features have been added to the small size of the TRUEresult twist 2 meter. These valuable, advanced new features simplify and promote more frequent testing enabling people with diabetes to take better control of their diabetes,” said Kurt Val Dal, President of the Board / CEO of Nipro Europe Group Companies. “With this new addition to our Diabetes Care product offering, we are continuing to deliver on our promise of providing people with diabetes and our business partners with high quality, cutting edge products.”

About Nipro Diagnostics, Inc

Based in Fort Lauderdale, Florida, USA, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes monitoring and management products. The company offers a portfolio of high- quality blood glucose monitoring systems and diabetes management products available around the world. Nipro Diagnostics is the exclusive supplier of blood glucose monitoring systems, co-branded under the TRUE name, to the world’s leading pharmacies, distributors and mail service providers. For more information, please visit www.niprodiagnostics.com

About Nipro Europe

Nipro Europe is a subsidiary of Nipro Corporation is engaged directly and through its subsidiaries principally in the sale of medical devices and pharmaceutical packaging glass products. Nipro’s medical device division is engaged in the sale of Infusion products, devices and disposables for dialysis treatments including but not limited to dialysis devices, water treatment devices, dialyzers, bloodlines and venous access devices. It is also active in the sale of diabetes and cardiovascular related products. For more information please visit www.nipro-europe.com.

Click here for the press release